Imagine a world where healthcare is just a click away, but the system behind it struggles to prove
Across the human genome, a narrow slice at the very start of genes keeps leaving the same telltale
A daily habit as ordinary as pouring a third or fourth cup of coffee may have aligned with a five-year edge in biological aging among people living with schizophrenia and mood disorders, hinting that moderation could matter more than any exotic supplement. The notion is surprising because coffee
Julia Lainster sits down with Ivan Kairatov, a seasoned biopharma leader with deep experience in oncology R&D, to unpack the latest data from OptiTROP-Lung05 and what it could mean for first-line NSCLC. They explore how a TROP2-directed antibody-drug conjugate combined with an immune checkpoint
In emergency rooms, prenatal clinics, and primary care offices alike, clinicians reach for
I'm thrilled to sit down with Ivan Kairatov, a biopharma expert with a profound understanding of
The landscape of rare disease drug development is littered with clinical failures. For every success, countless promising compounds fail to demonstrate efficacy in late-stage trials, often due to the…
Major policy changes are colliding with the complex economics of drug development. For B2B
Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is
For decades, the commercial spotlight in biopharma has shone the brightest on high-prevalence
Misdiagnosis is a problem facing medicine today. A significant reason for this challenge is that
Imagine a world where healthcare is just a click away, but the system behind it struggles to prove its worth—telehealth leaders face this challenge every day as they strive to balance quality care with operational sustainability. In an era where virtual care has become a vital part of the
Could a simple ultrasound, powered by cutting-edge technology, save countless newborn lives by
Imagine a simple stroll down the hallway revealing the future of a patient’s recovery from major
